Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Drug Discovery 2024

ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and with a prayer room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events....

Fierce Clinical Summit 2024

The Fierce Clinical Summit 2024 is the flagship event for clinical research and trial management professionals. The Fierce Clinical Summit 2024 is the flagship event for clinical research and trial management professionals. This year’s program...

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

weight loss but also maintain the strength and energy they need for a healthy life." The study is set to start December 2024 at the nuHx headquarters in West Palm Beach and conclude May 2025 with published study results to follow. nuBioAge and its...

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

the Phase 1 trial will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in early November 2024. The Phase 1 trial is conducted in collaboration with Cleveland Clinic and is funded by a grant from the U.S. Department of...

2nd Global Summit on Pharmaceutical and Medicinal Chemistry 2024

2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during September 23,25, 2024. 2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during...

Biotech Congress 2024

Biotech Congress 2024 (World Biotechnology and Bioengineering Congress) is an international conference organized by the Scholars Conferences scheduled during 23-24 September 2024 at Singapore. Biotech Congress 2024 (World Biotechnology and...

4th Edition of International Conference on Tissue Engineering and Regenerative Medicine 2024

4th Edition of International Conference on Tissue Engineering and Regenerative Medicine" (TERMC 2024), scheduled to take place in Rome, Italy with the added convenience of virtual attendance during September 19-21, 2024. 4th Edition of...

14th Annual DPHARM 2024

community to rethink how clinical research gets done to drive greater inclusivity and value for patients. DPHARM 2024 features senior clinical operation executives with industry and patient thought leadership, and technologists showcasing the...

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

and other bioactive substance innovations, showcased robust growth in its raw materials business in its newly released 2024 mid-year financial report. The company reported a total revenue of RMB 2.811 billion (~ USD 393.54 million) for the first...

Stealth BioTherapeutics announces an FDA advisory committee meeting to review Elamipretide for Barth syndrome treatment

will hold an advisory committee meeting with the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) on October 10, 2024 to evaluate the New Drug Application (NDA) for elamipretide, the first potential therapy for Barth syndrome. This...

3rd Biologics Contract Manufacturing Asia 2024

The 3rd Biologics Contract Manufacturing Asia 2024 is a premium event that focuses exclusively on Contract Manufacturing in Asia-Pacific. The 3rd Biologics Contract Manufacturing Asia 2024 is a premium event that focuses exclusively on Contract...

Lunit joins Roche's Digital Pathology Open Environment to advance cancer biomarker testing

of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as the ASCO and RSNA. In 2024, Lunit acquired Volpara Health Technologies, setting the stage for unparalleled synergy and accuracy, particularly in breast...

Genprex collaborators to present positive preclinical data on Reqorsa® gene therapy

for patients with cancer and diabetes, announced that its research collaborators were selected to present at the upcoming 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. The collaborators will present posters on positive...

11th Pharma Packaging & Labeling 2024

11th Pharma Packaging and Labeling Innovation Forum 2024 is an executive platform to discuss the industry challenges for Material & Design Innovations, Sustainability, Branding & Marketing, and Inspirational & Active Packaging. 11th Pharma...

Onco360 now offers LAZCLUZE™ (lazertinib) with Rybrevant® for first-line treatment of metastatic non-small cell lung cancer with specific EGFR mutations

Epidemiology, and End Results (SEER) Program, approximately 234,580 patients will be diagnosed with lung cancer in 2024, accounting for 11.7% of all new cancer cases, with approximately 125,070 expected patient deaths from prostate cancer in 2024,...

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

in a timely, safe and convenient way.” This year, the CDC recommends everyone ages 6 months and older receive updated 2024-2025 COVID-19 and flu vaccines, with rare exceptions. The CDC says that the concurrent administration of both vaccines is...

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

CVS Health® announced that the updated 2024-2025 COVID-19 vaccines and flu vaccines are available at CVS Pharmacy® and MinuteClinic® locations nationwide. Walk-ins are being accepted at CVS Pharmacy and the company's digital vaccine scheduler has...

Find Therapeutics announces FDA clearance of its IND application for a Phase 1 study of FTX-101 to treat chronic optic neuropathy

Phase 1 clinical study of FTX-101 in healthy volunteers. The company anticipates the commencement of the study in Q4 2024. "The FDA's clearance of our IND marks an important achievement for Find, allowing us to proceed with our Phase 1 study of...

China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

("Corina"), developed by Yipurun (Shanghai) Biotechnology Co., Ltd. ("YPR"), has received approval in China (G.X.Z.Z. 20243181461) for use in patients with moderate-to-severe intrauterine adhesions (IUA) who undergo transcervical resection of...

26th Asia-Pacific League of Associations for Rheumatology Congress 2024

Asia-Pacific League of Associations for Rheumatology Congress, set to take place in Singapore. Scheduled from 21-25 August 2024, this congress promises to be an exceptional gathering, embracing the vibrant spirit of Singapore and fostering an...

Results 61 - 80 of 114